%0 Journal Article
%A Jurayev J.S.,, Jurayev J.S.,
%A Karshiev.M.A, Karshiev.M.A
%A Uralov A.A, Uralov A.A
%D 2024
%F arxiv:97684
%J INTERNATIONAL CONFERENCE ON MEDICINE, SCIENCE, AND EDUCATION
%K extrahepatic manifestations, relapse, IFN + riboverine, retreatment of  relapse HCV RNA genotype 1b.
%N 4
%P 98-99
%T RECURRENCE OF CHCV AFTER THE USE OF DIRECT ANTIVIRAL  DRUGS: CLINICS, DIAGNOSIS, TREATMENT AND OUTCOMES
%U https://arxiv.universalpublishings.com/id/eprint/97684/
%V 1
%X Viral hepatitis C is one of the leading liver diseases. According to WHO, 70 million people are infected with this disease. HCV kills 290,000 people every year. In 95% of patients, the disease becomes chronic, and the main complications are fibrosis and cirrhosis of the liver. In some cases, a relapse is observed, despite treatment with antiviral drugs.